NewLink Genetics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

NewLink Genetics ( NLNK) is a development-stage company. NewLink Genetics is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. This stock is trading up 3.4% at $13.38 in recent trading.

Today's Volume: 138,000

Average Volume: 67,872

Volume % Change: 152%

From a technical perspective, NLNK is moving sharply higher here on above average volume. This move is quickly pushing NLNK within range of triggering a near-term breakout trade. That trade will hit once NLNK takes out some near-term overhead resistance at $13.67 with high volume.

At last check, NLNK has hit an intraday high of $13.78, which is also a new 52-week high on strong volume. Traders should continue to look for long-biased trades as long as NLNK is trending near or above $13.67 with strong upside volume flows. I would consider any upside volume day that registers near or above 67,872 shares as bullish. If we continue to see that action, then look for NLNK to trade north of $15 in the near future.

If you liked this article you might like

Analysts' Actions -- Adobe, AMD, Chegg, Okta and More

Collaboration Software Company Jive Spikes on Take-Private Offer

Stocks Under $10 Portfolio: Consumer Staples Overbought

PE Firms Upping Their Game in Public Markets

Facebook's New Workplace Service Is All About Keeping Users Hooked on Facebook